HB
GSK icon

Homrich & Berg’s GSK GSK Stock Holding History

Homrich & Berg’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,839
Closed -$202K – 295
2017
Q1 		$202K Buy
+3,839
New +$195K 0.02% 286
2016
Q4 		– Sell
-5,207
Closed -$281K – 275
2016
Q3 		$281K Buy
5,207
+35
+0.7% +$1.92K 0.03% 216
2016
Q2 		$280K Sell
5,172
-1,281
-20% -$67.5K 0.03% 210
2016
Q1 		$327K Buy
6,453
+67
+1% +$3.34K 0.03% 185
2015
Q4 		$322K Sell
6,386
-6,676
-51% -$340K 0.03% 192
2015
Q3 		$628K Sell
13,062
-4,232
-24% -$220K 0.07% 110
2015
Q2 		$900K Sell
17,294
-6,744
-28% -$380K 0.09% 88
2015
Q1 		$1.39M Buy
24,038
+664
+3% +$38.1K 0.14% 68
2014
Q4 		$1.25M Buy
23,374
+2,652
+13% +$148K 0.13% 69
2014
Q3 		$1.19M Buy
20,722
+108
+0.5% +$6.62K 0.12% 68
2014
Q2 		$1.38M Sell
20,614
-196
-0.9% -$13.3K 0.16% 58
2014
Q1 		$1.39M Sell
20,810
-221
-1% -$14.9K 0.18% 50
2013
Q4 		$1.4M Buy
21,031
+250
+1% +$16.2K 0.2% 42
2013
Q3 		$1.3M Buy
20,781
+240
+1% +$15.4K 0.21% 42
2013
Q2 		$1.28M Buy
+20,541
New +$1.3M 0.23% 40

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Homrich & Berg's GSK Position: Q2 2017 in Review

Homrich & Berg sold out of GSK (GSK) in Q2 2017, closing a stake of 3,839 shares — an estimated $202K sold.

Homrich & Berg first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $1.4M in Q4 2013. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Homrich & Berg reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Homrich & Berg sold 3,839 GSK shares in Q2 2017, an estimated $202K.
  • Homrich & Berg first reported a position in GSK in Q2 2013 and held it in 15 quarters.
  • Homrich & Berg's GSK position peaked at $1.4M in Q4 2013.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Homrich & Berg's 13F filing for Q2 2017, filed 8 Aug 2017.